Pharmacists in Guam - Medicare Status, Address, Contact
68 Pharmacists found. Showing 61 - 68
 Dr. Kenneth Won Lee, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 388 Ypao Rd, Tamuning, GU 96913 Phone: 671-648-2525 Fax: 671-648-2555 |
Mr. Patrick James Pang, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 548 S Marine Corps Dr, Tamuning, GU 96913 Phone: 671-646-5825 Fax: 671-647-3598 |
 Ms. Mildred Maniago Gabriel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 646 South Marine Drive, Guam Rexall Drugs, Tamuning, GU 96913 Phone: 671-646-4827 Fax: 671-649-0051 |
Carrie Margeson Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Bldg #50 Farenholt Ave, Tutuhan, GU 96910 Phone: 670-344-9354 |
June L Aggabao, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1244 North Marine Corps Drive, Upper Tumon, GU 96913 Phone: 671-646-6515 Fax: 671-646-6516 |
Mrs. Marilyn Hocson Florendo, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Community Pharmacy, 1244 North Marine Drive, Upper Tumon, GU 96913 Phone: 671-646-6515 Fax: 671-646-6516 |
Brett Christy Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26012 Carolines Ave, Andersen Afb, Yigo, GU 96929 Phone: 671-366-5271 |
Kristine S Feliciano Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 525 Chalan Ramon Haya, Yigo, GU 96929 Phone: 671-653-9512 Fax: 671-653-9515 |
News Archive
Researchers discover master switch for a tumor suppressive network
A decades-old cancer mystery has been solved by researchers at Cold Spring Harbor Laboratory (CSHL). "We not only found a critical tumor suppressor gene, but have revealed a master switch for a tumor suppressive network that means more targeted and effective cancer therapy in the future," said CSHL Associate Professor Alea Mills, Ph.D.
Children's National Health System completes deployment of MedAptus' Pro and Tech solutions
MedAptus today announced that Children's National Health System has completed deployment of the company's Pro and Tech solutions across its numerous outpatient care locations.
InSite Vision initiates Phase 1/2 clinical trial of ISV-303
InSite Vision Incorporated, a company developing novel ophthalmic therapeutics, today announced the initiation of a Phase 1/2 clinical trial of ISV-303, a topical anti-inflammatory product intended to reduce the pain and inflammation associated with ocular surgery. ISV-303 combines a low dose of the non-steroidal anti-inflammatory bromfenac with InSite Vision's proprietary DuraSite technology.
The internet may help sufferers of panic disorder
Internet-based treatments for sufferers of panic disorder may be just as effective as face-to-face methods, a study by Monash University researchers has found.
› Verified 5 days ago